Antioxidant compositions comprising extracts of myrtle and rosemary
First Claim
Patent Images
1. A composition consisting essentially of:
- a) from approximately 1 mg to 1000 mg of an extract of myrtle (Myrtus communis) produced starting from the leaves of the myrtle by solid/liquid extraction;
b) from approximately 1 mg to 1000 mg of an extract of rosemary (Rosmarinus officinalis) produced by starting from the leaves of the rosemary by solid/liquid extraction; and
c) therapeutically effective amounts of glucosamine, curcuma and chondroitin;
wherein, the combination of a) and b) has an antioxidant potency at least 5% greater than the sum of the antioxidant potencies of a) and b) as single extracts, as measured with the 2,2-diphenyl- 1-picryl-hydrazyl (DPPH) test.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a composition based on extracts of myrtle and rosemary which has been found to synergistically increase the protection of cells against pathophysiological conditions characterised and partly caused by overproduction of free radicals and to counteract the oxidative stress caused by excessive production of said free radicals, as well as for preventing and/or treating related pathologies, including apoptosis.
-
Citations
15 Claims
-
1. A composition consisting essentially of:
-
a) from approximately 1 mg to 1000 mg of an extract of myrtle (Myrtus communis) produced starting from the leaves of the myrtle by solid/liquid extraction; b) from approximately 1 mg to 1000 mg of an extract of rosemary (Rosmarinus officinalis) produced by starting from the leaves of the rosemary by solid/liquid extraction; and
c) therapeutically effective amounts of glucosamine, curcuma and chondroitin;
wherein, the combination of a) and b) has an antioxidant potency at least 5% greater than the sum of the antioxidant potencies of a) and b) as single extracts, as measured with the 2,2-diphenyl- 1-picryl-hydrazyl (DPPH) test. - View Dependent Claims (2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15)
-
-
8. A composition consisting essentially of :
-
a) from approximately 1 mg to 1000 mg of extract of myrtle (Myrtus communis) produced starting from the leaves of myrtle by solid/liquid extraction; b) from approximately 1 mg to 1000 mg of extract of rosemary (Rosmarinus officinalis) produced starting from the leaves of rosemary by solid/liquid extraction; and c) therapeutically effective amounts of helichrysum and curcuma; wherein, the combination of a) and b) has an antioxidant potency at least 5% greater than the sum of the antioxidant potencies of a) and b) as single extracts, as measured with the 2,2-diphenyl- 1-picryl-hydrazyl (DPPH) test.
-
-
9. A composition consisting essentially of:
-
a) from approximately 1 mg to 1000 mg of extract of myrtle (Myrtus communis) produced starting from the leaves of myrtle by solid/liquid extraction; b) from approximately 1 mg to 1000 mg of extract of rosemary (Rosmarinus officinalis) produced starting from the leaves of rosemary by solid/liquid extraction; and c) therapeutically effective amounts of CoQ10 and hawthorn; wherein, the combination of a) and b) has an antioxidant potency at least 5% greater than the sum of the antioxidant potencies of a) and b) as single extracts, as measured with the 2,2-diphenyl- 1-picryl-hydrazyl (DPPH) test.
-
Specification